Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Mariacarmela Santarpia, Elisa Giovannetti, Christian Rolfo, Niki Karachaliou, Maria González-Cao, Giuseppe Altavilla & Rafael Rosell. (2016) Recent developments in the use of immunotherapy in non-small cell lung cancer. Expert Review of Respiratory Medicine 10:7, pages 781-798.
Read now
Read now
Simona Carnio, Silvia Novello, Paolo Bironzo & Giorgio Vittorio Scagliotti. (2014) Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer. Expert Review of Anticancer Therapy 14:12, pages 1495-1513.
Read now
Read now
Francesca Casaluce, Assunta Sgambato, Paola Claudia Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello & Cesare Gridelli. (2014) Emerging drugs targeting PD-1 and PD-L1: reality or hope?. Expert Opinion on Emerging Drugs 19:4, pages 557-569.
Read now
Read now
Alexei Shimanovsky & Constantin A Dasanu. (2014) Updates on immunotherapy in non-small cell lung cancer. Expert Opinion on Biological Therapy 14:4, pages 411-418.
Read now
Read now
Marianne Davies. (2014) New modalities of cancer treatment for NSCLC: focus on immunotherapy. Cancer Management and Research 6, pages 63-75.
Read now
Read now
Vincent Varilla, Jonessa Atienza & Constantin A Dasanu. (2013) Immune alterations and immunotherapy prospects in head and neck cancer. Expert Opinion on Biological Therapy 13:9, pages 1241-1256.
Read now
Read now
Articles from other publishers (28)
O. I Kit, E. M. Frantsiyants, D. A. Kharagezov, V. A. Bandovkina, Yu. A. Pogorelova, N. D. Cheryarina, Yu. N. Lazutin, A. G. Milakin, I. A. Leyman, O. N. Stateshny & N. D. Ushakova. (2023) Levels of biogenic amines in lung tissues of patients with non-small cell lung cancer after COVID-19 of various severity. South Russian Journal of Cancer 4:2, pages 16-27.
Crossref
Crossref
Kun Zhang, Ke Wang, Chaoguo Zhang, Xiuli Teng, Dan Li & Mingwei Chen. (2022) Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. BMC Cancer 22:1.
Crossref
Crossref
Hafiza Padinharayil, Reema Rose Alappat, Liji Maria Joy, Kavya V. Anilkumar, Cornelia M. Wilson, Alex George, Abilash Valsala Gopalakrishnan, Harishkumar Madhyastha, Thiyagarajan Ramesh, Ezhaveni Sathiyamoorthi, Jintae Lee & Raja Ganesan. (2022) Advances in the Lung Cancer Immunotherapy Approaches. Vaccines 10:11, pages 1963.
Crossref
Crossref
Jianwei Zhu, Yun Yuan, Xiaoyu Wan, Dan Yin, Rui Li, Wenwen Chen, Chen Suo & Huan Song. (2021) Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent. Cochrane Database of Systematic Reviews 2021:12.
Crossref
Crossref
Shiyi Liu, Xujun Wang, Wenyi Qin, Georgi Z. Genchev & Hui Lu. (2018) Transcription Factors Contribute to Differential Expression in Cellular Pathways in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Interdisciplinary Sciences: Computational Life Sciences 10:4, pages 836-847.
Crossref
Crossref
Priya Ramanathan, Hemavathi Dhandapani, Hascitha Jayakumar, Abirami Seetharaman & Rajkumar Thangarajan. (2018) Immunotherapy for cervical cancer: Can it do another lung cancer?. Current Problems in Cancer 42:2, pages 148-160.
Crossref
Crossref
Qing TuZhou YangJianhui Gan, Jian Zhang, Bin Que, Qiaofeng Song & Yan Wang. (2018) Transcutaneous Electrical Acupoint Stimulation Improves Immunological Function During the Perioperative Period in Patients With Non-Small Cell Lung Cancer Undergoing Video-Assisted Thoracic Surgical Lobectomy. Technology in Cancer Research & Treatment 17, pages 153303381880647.
Crossref
Crossref
Jie Ma, Huaxi Xu & Shengjun Wang. (2018) Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer. Journal of Immunology Research 2018, pages 1-9.
Crossref
Crossref
Jianwei Zhu, Rui Li, Eva Tiselius, Raheleh Roudi, Olivia Teghararian, Chen Suo & Huan Song. (2017) Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ghina Fakhri, Reem Akel, Ziad Salem, Ayman Tawil & Arafat Tfayli. (2017) Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report. Case Reports in Oncology 10:3, pages 1070-1075.
Crossref
Crossref
Aránzazu Lafuente-Sanchis, Ángel Zúñiga, Miriam Estors, Néstor J. Martínez-Hernández, Antonio Cremades, María Cuenca & José M. Galbis. (2017) Association of PD-1 , PD-L1 , and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non–Small-Cell Lung Cancer. Clinical Lung Cancer 18:2, pages e109-e116.
Crossref
Crossref
Iwona Kwiecien, Anna Stelmaszczyk-Emmel, Malgorzata Polubiec-Kownacka, Dariusz Dziedzic & Joanna Domagala-Kulawik. (2016) Elevated regulatory T cells, surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans. Cancer Immunology, Immunotherapy 66:2, pages 161-170.
Crossref
Crossref
Yuh-Min Chen. (2017) Immune checkpoint inhibitors for nonsmall cell lung cancer treatment. Journal of the Chinese Medical Association 80:1, pages 7-14.
Crossref
Crossref
Priyanka Khanna, Normand Blais, Pierre-Olivier Gaudreau & Luis Corrales-Rodriguez. (2017) Immunotherapy Comes of Age in Lung Cancer. Clinical Lung Cancer 18:1, pages 13-22.
Crossref
Crossref
Shengdian Wang & Mingming Jia. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy
1
67
.
Huaxing Wu, Kun Wang, Guixian Li, Dexin Meng, Jiacheng Han, Guonian Wang & Yu Li. (2015) Effects of transcutaneous acupoint electrical stimulation�on the imbalance of Th1, Th2, Th17 and Treg cells following thoracotomy of patients with lung cancer. Experimental and Therapeutic Medicine.
Crossref
Crossref
Mei Ji, Yan Liu, Qing Li, Xiao-Dong Li, Wei-Qing Zhao, Hanze Zhang, Xiaofei Zhang, Jing-Ting Jiang & Chang-Ping Wu. (2015) PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation. Journal of Translational Medicine 13:1.
Crossref
Crossref
Abhisek Swaika, William A. Hammond & Richard W. Joseph. (2015) Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy. Molecular Immunology 67:2, pages 4-17.
Crossref
Crossref
Nicolas Guibert, Myriam Delaunay & Julien Mazières. (2015) Targeting the immune system to treat lung cancer: rationale and clinical experience. Therapeutic Advances in Respiratory Disease 9:3, pages 105-120.
Crossref
Crossref
Valsamo K. Anagnostou & Julie R. Brahmer. (2015) Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non–Small Cell Lung Cancer. Clinical Cancer Research 21:5, pages 976-984.
Crossref
Crossref
Haiyan Chen, Juan Zhao, Min Zhang, Haibo Yang, Yuxiang Ma & Yueqing Gu. (2014) MUC1 Aptamer-Based Near-Infrared Fluorescence Probes for Tumor Imaging. Molecular Imaging and Biology 17:1, pages 38-48.
Crossref
Crossref
Huan Song, Jianwei Zhu & DongHao Lu. (2014) Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Huan Song, Jianwei Zhu, Chen Suo & DongHao Lu. (2014) Immunotherapy for stage I-III non-small cell lung cancer treated with surgery or radiotherapy with curative intent. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Dawn E. DolanShilpa Gupta. (2014) PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy. Cancer Control 21:3, pages 231-237.
Crossref
Crossref
Nora Bittner, Gyula Ostoros & Lajos Géczi. (2013) New Treatment Options for Lung Adenocarcinoma - in View of Molecular Background. Pathology & Oncology Research 20:1, pages 11-25.
Crossref
Crossref
Laura QM Chow. (2013) Exploring Novel Immune-Related Toxicities and Endpoints with Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer. American Society of Clinical Oncology Educational Book:33, pages e280-e285.
Crossref
Crossref
Puneeth Iyengar & David E. Gerber. (2013) Locally Advanced Lung Cancer. The Cancer Journal 19:3, pages 247-262.
Crossref
Crossref
Julie R. Brahmer. (2013) Harnessing the Immune System for the Treatment of Non–Small-Cell Lung Cancer. Journal of Clinical Oncology 31:8, pages 1021-1028.
Crossref
Crossref